Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Research
←Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America
The Trump-Backed Federal Budget Threatens Black Economic Progress. Here’s How Black Communities Can Reclaim Their Power→

More posts

  • Judge sets hearing for Venezuelan man shot by ICE, and police in Texas release video

  • Dolly Parton’s estate accuses her nephew of threatening violence and to destroy his aunt’s legacy

  • Trump administration to remove 760,000 Affordable Care Act enrollees over fraud claims

  • Hunting hidden gems – is there anywhere in the world left to scout?

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube